Strategic Supply Agreement Bolsters Decibel's Presence In UK And European Cannabis Markets

Decibel Cannabis Company Inc. DBDBCCF, a prominent player in premium cannabis and extract products has taken a significant stride in its global expansion strategy.

UK Partnership: A Gateway To European Expansion

The Canadian company has inked a supply agreement with 4C LABS, a leading UK-based healthcare, technology and pharmaceutical firm specializing in cannabis-based medicinal products. This move solidifies Decibel's foothold in the UK market.

Adam Coates, CRO at Decibel, expressed enthusiasm for the collaboration, noting its potential to penetrate not only the UK market but also broader European markets.

"Decibel's success with Qwest flower products in Canada and in Israel's medical market reinforces the demand for premium cannabis products and the reputation we have built to service that demand," Coates said.

Greg Dobbin, CEO of 4C LABS, praised Decibel's reputation for quality, innovation, and attention to detail, asserting that the partnership would cater to UK patients' needs effectively. 

Cannabis Supply Deal

Under the 3-year supply agreement, Decibel will provide premium dried medical cannabis flower, branded as Qwest, exclusively to 4C LABS for distribution to medical cannabis patients in the UK.

The deal encompasses rare and unique cultivars, granting 4C LABS strain exclusivity.

The partnership is set to create a synergy between Decibel's expertise in crafting quality cannabis products and 4C LABS' patient-centric approach.

Find strategic opportunities to expand your cannabis business at the next Benzinga Cannabis Capital Conference, the place where deals get done, which is returning to Chicago this September 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.

Photo by Christian Lue on Unsplash.